{"id":64623,"date":"2022-06-07T13:03:39","date_gmt":"2022-06-07T11:03:39","guid":{"rendered":"http:\/\/www.veeva.com\/eu\/?post_type=resources&p=64623"},"modified":"2026-01-27T15:27:49","modified_gmt":"2026-01-27T14:27:49","slug":"veeva-announces-clinical-study-training-application","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-announces-clinical-study-training-application\/","title":{"rendered":"Veeva Announces Clinical Study Training Application"},"content":{"rendered":"

Veeva Study Training unifies learning management and clinical operations for integrated and
automated training and real-time inspection readiness<\/em><\/p>\n

BARCELONA, Spain \u2014 7 June 2022 \u2014 <\/strong>Veeva Systems<\/a> (NYSE: VEEV) today announced Veeva Study Training<\/a>, a new application that brings together research sites, CROs, and sponsors into a single platform for end-to-end clinical study training. Organizations using Veeva Study Training can ensure all trial staff are qualified within required timelines while automating the filing of training certificates into Veeva eTMF<\/a> for real-time inspection readiness.<\/p>\n

\u201cVeeva continues to collaborate closely with the industry to identify gaps in key processes across clinical development and deliver innovations that can improve operational efficiency,\u201d said Ed Leftin, director, information technology at Ora, Inc. \u201cThe ability to use existing data and content in Veeva Clinical Suite to create training, from study start to conduct, can streamline study execution and improve compliance.\u201d<\/p>\n

Veeva Study Training builds on Veeva\u2019s experience working with more than 450 companies using Veeva Clinical Platform<\/a> applications and learnings from hundreds of Veeva Training<\/a> implementations. Life sciences companies can now address the long-standing industry challenge of training study staff and site personnel in an efficient and compliant way. <\/p>\n

Veeva\u2019s complete and connected solution will allow life sciences companies to leverage current clinical master data and content to remove issues like redundant information, manual data entry, and siloed processes. Veeva Study Training automates assignment distribution, protocol amendment management, and training certificate filing for increased efficiency and reduced end of study reconciliation. <\/p>\n

\u201cAs studies evolve and reach new levels of complexity, companies need a streamlined and integrated training system that can scale with the demands of today\u2019s trials,\u201d said Shad Ayoub, senior director, Veeva Study Training. \u201cVeeva Study Training will deliver a fundamentally better experience to sites, CROs, and sponsors.\u201d<\/p>\n

Veeva Study Training will be available to early adopters in fall 2022. To learn more about Veeva Study Training, visit veeva.com\/eu\/VaultStudyTraining<\/a>. <\/p>\n

Additional Information<\/strong>
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veeva_eu on Twitter: twitter.com\/veeva_eu<\/a><\/br>\n<\/p>\n

About Veeva Systems<\/strong>
\nVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world\u2019s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n

Veeva Forward-looking Statements<\/strong>
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2022, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at sec.gov<\/a>. <\/p>\n

###<\/p>\n

Contact:<\/strong><\/p>\n

Deivis Mercado
\nVeeva Systems
\n925-226-8821
\ndeivis.mercado@veeva.com<\/a><\/p>\n

Jeremy Whittaker
\nVeeva Systems
\n+49 6950955486
\njeremy.whittaker@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Veeva Study Training unifies learning management and clinical operations for integrated and automated training.<\/p>\n","protected":false},"featured_media":64632,"parent":0,"template":"","class_list":["post-64623","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-clinical-operations","resource-area-20-vault-platform-area","resource-product-20-study-training","resource-product-20-vault-platform","resource-type-news-press-release","resource-type-press-release","region-fr"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/64623"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/64623\/revisions"}],"predecessor-version":[{"id":64631,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/64623\/revisions\/64631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/64632"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=64623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}